Immediate Impact

34 standout
Sub-graph 1 of 17

Citing Papers

Determinants of behaviour and their efficacy as targets of behavioural change interventions
2024 Standout
Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial
2022 Standout
2 intermediate papers

Works of W Kratzer being referenced

If–then planning modulates the P300 in children with attention deficit hyperactivity disorder
2007
Axonal Neuropathy and Predominance of Type II Myofibers in Infantile Spinal Muscular Atrophy
1998

Author Peers

Author Last Decade Papers Cites
W Kratzer 56 43 20 48 27 211
Chukwuyem Ekhator 59 33 14 34 47 242
Jie Peng 51 71 25 12 26 268
Allen Perkins 36 38 55 36 18 297
Zvi Segal 25 16 40 35 28 278
Douglas S. Ruhl 83 36 16 25 29 286
Victoria Bartlett 23 21 17 13 16 291
Yun Yu 14 23 25 68 25 259
Anas Belouali 8 37 37 28 24 245
Mustafa Motiwala 40 47 19 22 28 265
Wesley Furnback 35 26 31 14 24 264

All Works

Loading papers...

Rankless by CCL
2026